Locally Advanced Solid Tumor
Showing 26 - 50 of >10,000
Advanced Or Metastatic Solid Tumor Malignancies Trial (SHR-A2102)
Not yet recruiting
- Advanced Or Metastatic Solid Tumor Malignancies
- (no location specified)
Feb 9, 2023
Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)
Not yet recruiting
- Cancer
- +6 more
- KB707
- (no location specified)
Jul 24, 2023
Advanced Solid Tumor Trial in Shanghai (HY-0102)
Not yet recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 19, 2023
Solid Tumor Trial in Chuo Ku (SAIL66, Tocilizumab)
Not yet recruiting
- Solid Tumor
-
Chuo Ku, Tokyo, JapanNational Cancer Center Hospital
Feb 9, 2023
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8
Recruiting
- Advanced Solid Tumor
- +6 more
- TransCon TLR7/8 Agonist
- Pembrolizumab
-
Duarte, California
- +12 more
Sep 21, 2022
Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)
Recruiting
- Solid Tumor
-
Chuo-ku, Tokyo, JapanNational Cancer Center Hospital
Jun 14, 2023
Locally Advanced/Metastatic Solid Tumors Trial (PE0116&PE0105)
Not yet recruiting
- Locally Advanced/Metastatic Solid Tumors
- (no location specified)
Mar 24, 2023
Locally Advanced/Metastatic Solid Tumors Trial in Shanghai (PE0116)
Active, not recruiting
- Locally Advanced/Metastatic Solid Tumors
-
Shanghai, China复旦大学附属中山医院
Mar 23, 2023
Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (NVL-655)
Recruiting
- Locally Advanced Solid Tumor
- Metastatic Solid Tumor
-
Orange, California
- +13 more
Jan 31, 2023
HER2-positive, Locally Advanced Solid Tumor, Immunotherapy Trial in Beijing (sintilimab, Trastuzumab, S-1 plus oxaliplatin)
Not yet recruiting
- HER2-positive
- +6 more
- sintilimab
- +2 more
-
Beijing, ChinaCancer Hospital & Institute, Chinese Academy of Medical Sciences
Mar 28, 2022
Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies Trial in Chuo-ku (ASP1948)
Completed
- Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
-
Chuo-ku, Tokyo, JapanSite JP810001
Jan 17, 2023
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Terminated
- Locally Advanced Malignant Solid Neoplasm
- +2 more
- Pembrolizumab
- Pevonedistat
-
Houston, TexasM D Anderson Cancer Center
Dec 22, 2022
Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor Trial (TYRA-300)
Not yet recruiting
- Locally Advanced Urothelial Carcinoma
- +3 more
- (no location specified)
Sep 15, 2022
Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Trial in Shanghai (Phase I
Not yet recruiting
- Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
- Phase I dose escalation
- +3 more
-
Shanghai, Shanghai, ChinaFudan Cancer Hospital
Apr 24, 2023
Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in China (VC004)
Recruiting
- Locally Advanced Solid Tumor
- Metastatic Solid Tumor
-
Hefei, Anhui, China
- +20 more
Dec 11, 2022
Investigating the Impact of Proactive Palliative Care
Active, not recruiting
- Metastatic Solid Tumor Cancers
- Locally Advanced Solid Tumor Cancers
- Expectations Survey (CanCORS)
- +6 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 2, 2022
Solid Tumor Trial in Shenyang (Intravenous infusion anti-HER2-CAR-T cell)
Not yet recruiting
- Solid Tumor
- Intravenous infusion anti-HER2-CAR-T cell
-
Shenyang, Liaoning, ChinaPhase I Clinical Trials Center Of The First Hospital of China Me
Oct 30, 2023